← Back to headlines
Summit Therapeutics Rises as Akeso Wins China Drug Label Expansion
Summit Therapeutics saw its stock rise after its partner Akeso secured a label expansion in China for its leading drug, indicating positive regulatory developments.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Volkswagen Board Approves Restructuring Plan to Cut 100,000 Jobs by 2030
32m ago
Trump Administration Asks Supreme Court to Lift Block on Mail Ballot Restrictions
40m ago
New US-Venezuela Oil Agreement Draws Sharp Criticism and Economic Skepticism
2h ago
Crusoe Secures $3 Billion Funding and Lands $13 Billion Cloud Deal
2h ago